All Type of News
Whanin Pharm to distribute Novartis’s Clozaril
Whanin Pharmaceutical said Tuesday that it had signed a distribution agreement with Novartis Korea for the exclusive sale of the latter’s Clozaril (clozapine) here, starting in July 1.
Clozapine is an atypical anti...
Health insurance premium to rise 1.7%
The Ministry of Health and Welfare said Tuesday it will raise health insurance premiums by 1.7 percent beginning next year.
Under the ministry's plan, individual subscribers and workplace subscribers must pay an a...
Korea ranks 7th in global pharmaceutical patent filings
Korea ranked seventh and eighth last year in the number of international patent applications related to pharmaceutical and medical device sectors, with Osstem Implant leading the way.
The nation filed for 825 inter...
Public pharmacist plan hits snag
There are concerns that the public pharmacist plan, which is designed to fix the shortage of pharmacists in rural areas, could be derailed.
“At this moment, we don't have any plan to introduce the new system due to...
National Assembly Health and Welfare Committee to screen 92 bills
The National Assembly’s Health and Welfare Committee plans to deal with 92 bills related to the national subsidy for local public medical centers, anti-rebate measures and special provisions of Ginseng Industry Promot...
Ildong Pharm hike Bayer’s OTC drugs by up to 10%
Ildong Pharmaceutical has recently jacked up the retail prices of over-the-counter (OTC) products transferred by Bayer Korea by 5 to 10 percent.
According to the company, Canesten (clotrimazole) rose by five percen...
Celltrion CEO’s stake sell-off plan yet to be finalized
Celltrion said Monday that the company has yet to finalize its plan to sell the entire controlling stake of Celltrion Chairman and CEO Seo Jung-jin to a multinational pharmaceutical company.
In a regulatory filing ...
National Assembly seeks to pass anti-rebate bill
The National Assembly’s Health and Welfare Committee plans to discuss the anti-rebate bill designed to put an end to the corrupt practice and enhance transparency in the transactions and price-setting process of the m...
No additional drug price cuts are planned: Ministry of Health and Welfare
The Ministry of Health and Welfare said Friday it has no plan to go ahead with an additional drug price cuts this year.
In an interview with a daily newspaper, the ministry’s official Lee Dong-wook said that drug f...
Drug makers unnerved by shortsightedness
Korea’s drug companies have stepped up efforts to expand the scope of its role by actively participating in the government-initiated job creation campaign and boosting their shrinking marketing activities.
Ironical...
